Stenting of symptomatic basilar and vertebral artery stenosis in patients resistant to optimal medical prevention: The Lyon stroke unit experience

European Neurology

Volumn 60, Issue 3, 2008, Pages 127-131

  Ralea, Ionela Camelia ^a   Nighoghossian, Norbert ^b,c   Tahon, Florence ^a   Derex, Laurent ^b   Cakmak, Serkan ^a   Trouillas, Paul ^b   Turjman, Francis ^a  

^a Cerebrovascular Unit

^b UNIVERSITÉ DE LYON   (France)

^c HÔPITAL NEUROLOGIQUE   (France)

Author keywords

Angioplasty; Stenting; Vertebrobasilar stroke

Indexed keywords

ADULT; AGED; ARTICLE; BASILAR ARTERY; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; STENT; STROKE; TRANSIENT ISCHEMIC ATTACK; VERTEBRAL ARTERIOGRAPHY; VERTEBRAL ARTERY; VERTEBROBASILAR INSUFFICIENCY;

EID: 50449094349     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000144082     Document Type: Article

References (11)

1. Glass TA, Hennessey PM, Pazdera L, Chang HM, Wityk RJ, Dewitt LD, Pessin MS, Caplan LR: Outcome at 30 days in the New England Medical Center Posterior Circulation Registry. Arch Neurol 2002;59:369-376.
2. Thijs V, Albers G: Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy. Neurology 2000;55:490-498.
3. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG: Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis: the WASID study. N Engl J Med 2005;352:1305-1316.
4. Meyers PM, Schumacher HC, Tanji K, Higashida RT, Caplan LR: Use of stents to treat intracranial cerebrovascular disease. Annu Rev Med 2007;58:107-122.
5. Gupta R, Firas AA, Thomas AJ, Horowitz MB, Barrow T, Vora NA, Uchino K, Hammer MD, Wechsler LR, Jovin TG: Safety, feasibility and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation. Stroke 2006;2562-2568.
6. Gupta R, Zaidat O, Majid A: US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke 2007;38:e80.
7. The SSYLVIA Study Investigators: Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries: the SSYLVA study. Stroke 2004;35:1388-1392.
8. Coward LJ, McCabe DJ, Ederle J, Featherstone RL, Clifton A, Brown MM, CAVATAS Investigators: Long-term outcome after angioplasty and stenting for symptomatic vertebral artery stenosis compared with medical treatment in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomized trial. Stroke 2007;38:1526-1530.
9. Kasner SE, Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Benesch CG, Sila CA, Jovin TG, Romano JG, Cloft HJ, Warfarin Aspirin Symptomatic Intracranial Disease Trial Investigators: Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006;113:555-563.
10. Purroy F, Montaner J, Rovira A, Delgado P, Quintana M, Alvarez-Sabin J: Higher risk of further vascular events among transient ischemic attack patients with diffusion-weighted imaging acute ischemic lesions. Stroke 2004;35:2313-2319.
11. Jiang WJ, Xu XT, Du B, Dong KH, Jin M, Wang QH, Ma N: Long-term outcome of elective stenting for symptomatic intracranial vertebrobasilar stenosis. Neurology 2007;68:856-858.